Freestone Capital Holdings’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,548
Closed -$356K 444
2022
Q2
$356K Sell
4,548
-3,026
-40% -$250K 0.01% 318
2022
Q1
$646K Buy
7,574
+550
+8% +$52.7K 0.03% 302
2021
Q4
$842K Buy
7,024
+1,426
+25% +$177K 0.04% 252
2021
Q3
$692K Buy
5,598
+1,224
+28% +$158K 0.03% 249
2021
Q2
$525K Sell
4,374
-21
-0.5% -$2.4K 0.03% 276
2021
Q1
$462K Sell
4,395
-508
-10% -$51.5K 0.03% 278
2020
Q4
$499K Buy
4,903
+839
+21% +$78.9K 0.03% 252
2020
Q3
$342K Buy
+4,064
New +$316K 0.02% 261

Other funds holding XYL

Freestone Capital Holdings's XYL Position: Q3 2022 in Review

Freestone Capital Holdings sold out of Xylem (XYL) in Q3 2022, closing a stake of 4,548 shares — an estimated $356K sold.

Freestone Capital Holdings first reported a position in XYL in Q3 2020 and held it in 8 quarters. The position peaked at $842K in Q4 2021. 740 funds tracked by Wall St. Rank hold XYL as of Q3 2022.

  • Freestone Capital Holdings reported no remaining Xylem position as of Q3 2022 after selling out during the quarter.
  • Freestone Capital Holdings sold 4,548 Xylem shares in Q3 2022, an estimated $356K.
  • Freestone Capital Holdings first reported a position in Xylem in Q3 2020 and held it in 8 quarters.
  • Freestone Capital Holdings's Xylem position peaked at $842K in Q4 2021.
  • 740 funds tracked by Wall St. Rank held Xylem as of Q3 2022.

Based on Freestone Capital Holdings's 13F filing for Q3 2022, filed 9 Nov 2022.